News Update: What You Need to Know About the Court Case Attacking Access to Mifepristone in the United States

PAI announces acceptance into the WHO Civil Society Commission. Read more about the Commission: Read More
Despite representing a minuscule fraction of overall discretionary spending by the federal government—six one-hundredths of one percent (0.06%) in FY 2017—U.S. international FP/RH assistance has generated disproportionate political opposition from anti-contraception activists both inside and outside the U.S. government. At the same time, the program has delivered innumerable health, social, and economic benefits to women around the world.
Stay informed about the issues impacting sexual and reproductive health and rights.